For laboratory & research purposes only · Not for human consumption · RUO
Sale20% off with code PEAKSALEBuy 2, get the 3rd 60% offBuy 4, get 2 free

Endotoxin testing: LAL, recombinant Factor C, and what 'within limit' means

·8 min readanalytical methodspecificationendotoxin

Why a sterile material can still carry endotoxin, how the limulus amebocyte lysate assay works, what recombinant Factor C changed, and how to read an endotoxin result on a certificate of analysis.

Endotoxin is the assay most often missing from a research peptide certificate, and the one whose absence is least noticed — largely because sterility is assumed to cover it. It does not. The two are separate properties, measured by separate methods, and a material can pass one comprehensively while failing the other.

What endotoxin is

Endotoxin is lipopolysaccharide, a structural component of the outer membrane of Gram-negative bacteria. It is not something bacteria secrete as a toxin in the ordinary sense; it is part of the cell envelope, released in quantity when the cell is disrupted.

The molecule has three regions — a lipid A anchor embedded in the membrane, a core oligosaccharide, and a variable O-antigen polysaccharide chain. Lipid A is the biologically active portion and the part detection chemistry responds to.

Killing the bacteria does not remove the endotoxin

Lipopolysaccharide is a heat-stable amphiphilic molecule. Autoclaving destroys the organism and leaves the lipopolysaccharide substantially intact — in fact lysing cells releases more of it. Sterility and endotoxin content are genuinely independent results.

This is the crux of why both assays appear on a specification. A sterile filtration step removes intact organisms while passing free lipopolysaccharide, which is far smaller than the pore size. A material can be sterile, correctly so, and carry endotoxin from upstream water, raw materials or equipment.

How the assay works

The standard method exploits a defence mechanism of the horseshoe crab. Its blood contains amebocytes carrying a protease cascade that coagulates on contact with endotoxin, walling off an infection. Lysate prepared from those cells — limulus amebocyte lysate, or LAL — reproduces the reaction in a tube.

Endotoxin activates Factor C, the first enzyme in the cascade. Factor C activates Factor B, which activates a clotting enzyme, which acts on a substrate. The cascade amplifies at each step, which is what gives the assay its sensitivity. Three formats read the result differently:

FormatWhat is measuredOutput
Gel-clotWhether a solid clot formsPass or fail against a threshold
TurbidimetricRate of increase in turbidityQuantitative
ChromogenicCleavage of a colour-releasing substrateQuantitative

Results are reported in endotoxin units per millilitre or per milligram. The unit is defined against an international reference standard rather than as an absolute mass, because potency varies with lipopolysaccharide structure.

Recombinant Factor C

The LAL assay depends on a supply chain that begins with wild horseshoe crabs, which raises both sustainability and consistency questions. Recombinant Factor C addresses this by producing the first enzyme of the cascade recombinantly and reading its activation with a fluorogenic substrate — no animal-derived lysate, and no cascade beyond the initiating step.

The method has been evaluated extensively against the established one. Comparative studies on biopharmaceutical products have assessed recombinant reagents directly against LAL [1][2], broader evaluations have examined recombinant alternatives for assessment purposes alongside the traditional assay [4], and the position that recombinant testing represents a settled rather than experimental option has been argued in the analytical literature [3].

Because it starts from a single defined recombinant protein, the recombinant format also removes a source of lot-to-lot variability inherent in a biological lysate. Pharmacopoeial recognition has followed, and harmonisation of the bacterial endotoxin test across pharmacopoeias remains an active process [5].

Interference is the practical difficulty

The assay is an enzyme cascade, and sample matrices can interfere with it in both directions. Enhancement produces an inflated reading. Inhibition suppresses a genuine one, which is the more dangerous failure because it reports clean material that is not.

A related phenomenon, low endotoxin recovery or masking, occurs where endotoxin present in a sample becomes undetectable over time through interaction with components of the formulation. It is an active area of study precisely because it produces a false pass, and the extent of masking varies between detection systems.

This is why a valid result requires a positive product control — a known quantity of endotoxin spiked into the sample matrix and recovered within a defined range. Without it, a clean result is uninterpretable: there is no evidence the assay would have detected endotoxin in that matrix had it been present.

Reading the result

  • A number with units — the most informative form, letting you compare against whatever limit your work requires.
  • 'Within limit' or 'Pass' — a comparison against a stated threshold. Useful only if the threshold is stated.
  • 'Report' — the assay was run and the value recorded without a pass/fail applied.
  • Absent — the assay was not run. Purity and sterility results say nothing about endotoxin.

A limit is only meaningful relative to an intended application, and for research material the supplier does not know the application. That is the honest argument for reporting a figure rather than a verdict: the number lets the person doing the work apply their own threshold.

Endotoxin appears on our release specification as its own line, alongside sterility rather than folded into it, on every product page.

This article describes analytical methodology. It does not describe the use, effect or application of any compound. All products are supplied for laboratory and research purposes only.

References

Primary sources for the analytical claims above, linked so you can read them directly rather than take our word for it.

  1. [1]
    Study of LAL and Recombinant Cascade Reagents Methods for Bacterial Endotoxin Testing in Pharmaceutical Products
    Thota P, Kumar P, Teotia AK et al. · PDA J Pharm Sci Technol · 2026 · PMID 41844320
  2. [2]
    A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals
    Kang DH, Yun SY, Eum S et al. · Microorganisms · 2024 · PMID 38543567
  3. [3]
    Recombinant bacterial endotoxin testing: a proven solution
    Tindall B, Demircioglu D, Uhlig T · Biotechniques · 2021 · PMID 33956506
  4. [4]
  5. [5]
Related reading